Literature DB >> 22665165

Metabolomics reveals an essential role for peroxisome proliferator-activated receptor α in bile acid homeostasis.

Fei Li1, Andrew D Patterson, Kristopher W Krausz, Naoki Tanaka, Frank J Gonzalez.   

Abstract

Peroxisome proliferator-activated receptor α (PPARα) is a nuclear receptor that regulates fatty acid transport and metabolism. Previous studies revealed that PPARα can affect bile acid metabolism; however, the mechanism by which PPARα regulates bile acid homeostasis is not understood. In this study, an ultraperformance liquid chromatography coupled with electrospray ionization qua dru pole time-of-flight mass spectrometry (UPLC-ESI-QTOFMS)-based metabolomics approach was used to profile metabolites in urine, serum, and bile of wild-type and Ppara-null mice following cholic acid (CA) dietary challenge. Metabolomic analysis showed that the levels of several serum bile acids, such as CA (25-fold) and taurocholic acid (16-fold), were significantly increased in CA-treated Ppara-null mice compared with CA-treated wild-type mice. Phospholipid homeostasis, as revealed by decreased serum lysophos phati dylcholine (LPC) 16:0 (1.6-fold) and LPC 18:0 (1.6-fold), and corticosterone metabolism noted by increased urinary excretion of 11β-hydroxy-3,20-dioxopregn-4-en-21-oic acid (20-fold) and 11β,20α-dihydroxy-3-oxo-pregn-4-en-21-oic acid (3.6-fold), were disrupted in CA-treated Ppara-null mice. The hepatic levels of mRNA encoding transporters Abcb11, Abcb4, Abca1, Abcg5, and Abcg8 were diminished in Ppara-null mice, leading to the accumulation of bile acids in the liver during the CA challenge. These observations revealed that PPARα is an essential regulator of bile acid biosynthesis, transport, and secretion.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22665165      PMCID: PMC3540854          DOI: 10.1194/jlr.M027433

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  49 in total

1.  The murine and human cholesterol 7alpha-hydroxylase gene promoters are differentially responsive to regulation by fatty acids mediated via peroxisome proliferator-activated receptor alpha.

Authors:  S K Cheema; L B Agellon
Journal:  J Biol Chem       Date:  2000-04-28       Impact factor: 5.157

2.  Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis.

Authors:  P L Jansen; S S Strautnieks; E Jacquemin; M Hadchouel; E M Sokal; G J Hooiveld; J H Koning; A De Jager-Krikken; F Kuipers; F Stellaard; C M Bijleveld; A Gouw; H Van Goor; R J Thompson; M Müller
Journal:  Gastroenterology       Date:  1999-12       Impact factor: 22.682

3.  Tumor necrosis factor-alpha stimulates adrenal glucocorticoid secretion in cholestatic rats.

Authors:  M G Swain; M Maric
Journal:  Am J Physiol       Date:  1996-06

4.  The peroxisome proliferator-activated receptor alpha (PPARalpha) regulates bile acid biosynthesis.

Authors:  M C Hunt; Y Z Yang; G Eggertsen; C M Carneheim; M Gåfvels; C Einarsson; S E Alexson
Journal:  J Biol Chem       Date:  2000-09-15       Impact factor: 5.157

5.  Fibrates suppress bile acid synthesis via peroxisome proliferator-activated receptor-alpha-mediated downregulation of cholesterol 7alpha-hydroxylase and sterol 27-hydroxylase expression.

Authors:  S M Post; H Duez; P P Gervois; B Staels; F Kuipers; H M Princen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-11       Impact factor: 8.311

6.  Untargeted metabolomics identifies enterobiome metabolites and putative uremic toxins as substrates of organic anion transporter 1 (Oat1).

Authors:  William R Wikoff; Megha A Nagle; Valentina L Kouznetsova; Igor F Tsigelny; Sanjay K Nigam
Journal:  J Proteome Res       Date:  2011-04-22       Impact factor: 4.466

7.  Urinary metabolomics in Fxr-null mice reveals activated adaptive metabolic pathways upon bile acid challenge.

Authors:  Joo-Youn Cho; Tsutomu Matsubara; Dong Wook Kang; Sung-Hoon Ahn; Kristopher W Krausz; Jeffrey R Idle; Hans Luecke; Frank J Gonzalez
Journal:  J Lipid Res       Date:  2009-11-09       Impact factor: 5.922

8.  Role of farnesoid X receptor in the enhancement of canalicular bile acid output and excretion of unconjugated bile acids: a mechanism for protection against cholic acid-induced liver toxicity.

Authors:  Masaaki Miyata; Aki Tozawa; Hijiri Otsuka; Toshifumi Nakamura; Kiyoshi Nagata; Frank J Gonzalez; Yasushi Yamazoe
Journal:  J Pharmacol Exp Ther       Date:  2004-10-01       Impact factor: 4.030

Review 9.  Peroxisome proliferator-activated receptor alpha target genes.

Authors:  S Mandard; M Müller; S Kersten
Journal:  Cell Mol Life Sci       Date:  2004-02       Impact factor: 9.261

10.  Comprehensive analysis of PPARalpha-dependent regulation of hepatic lipid metabolism by expression profiling.

Authors:  Maryam Rakhshandehroo; Linda M Sanderson; Merja Matilainen; Rinke Stienstra; Carsten Carlberg; Philip J de Groot; Michael Müller; Sander Kersten
Journal:  PPAR Res       Date:  2007       Impact factor: 4.964

View more
  28 in total

1.  Peroxisome proliferator-activated receptor α activates human multidrug resistance transporter 3/ATP-binding cassette protein subfamily B4 transcription and increases rat biliary phosphatidylcholine secretion.

Authors:  Nisanne S Ghonem; Meenakshisundaram Ananthanarayanan; Carol J Soroka; James L Boyer
Journal:  Hepatology       Date:  2014-01-27       Impact factor: 17.425

2.  Celastrol ameliorates acute liver injury through modulation of PPARα.

Authors:  Qi Zhao; Ping Tang; Ting Zhang; Jian-Feng Huang; Xue-Rong Xiao; Wei-Feng Zhu; Frank J Gonzalez; Fei Li
Journal:  Biochem Pharmacol       Date:  2020-05-26       Impact factor: 5.858

3.  Poisoning with Soman, an Organophosphorus Nerve Agent, Alters Fecal Bacterial Biota and Urine Metabolites: a Case for Novel Signatures for Asymptomatic Nerve Agent Exposure.

Authors:  Derese Getnet; Aarti Gautam; Raina Kumar; Allison Hoke; Amrita K Cheema; Franco Rossetti; Caroline R Schultz; Rasha Hammamieh; Lucille A Lumley; Marti Jett
Journal:  Appl Environ Microbiol       Date:  2018-10-17       Impact factor: 4.792

4.  Identification and characterization of a novel PPARα-regulated and 7α-hydroxyl bile acid-preferring cytosolic sulfotransferase mL-STL (Sult2a8).

Authors:  Lu Feng; Yee-Lok Yuen; Jian Xu; Xing Liu; Martin Yan-Chun Chan; Kai Wang; Wing-Ping Fong; Wing-Tai Cheung; Susanna Sau-Tuen Lee
Journal:  J Lipid Res       Date:  2017-04-25       Impact factor: 5.922

5.  Celastrol Protects From Cholestatic Liver Injury Through Modulation of SIRT1-FXR Signaling.

Authors:  Qi Zhao; Fang Liu; Yan Cheng; Xue-Rong Xiao; Dan-Dan Hu; Ying-Mei Tang; Wei-Min Bao; Jin-Hui Yang; Tao Jiang; Jia-Peng Hu; Frank J Gonzalez; Fei Li
Journal:  Mol Cell Proteomics       Date:  2019-01-07       Impact factor: 5.911

6.  Hepatocyte peroxisome proliferator-activated receptor α regulates bile acid synthesis and transport.

Authors:  Cen Xie; Shogo Takahashi; Chad N Brocker; Shijun He; Li Chen; Guomin Xie; Katrina Jang; Xiaoxia Gao; Kristopher W Krausz; Aijuan Qu; Moshe Levi; Frank J Gonzalez
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2019-06-10       Impact factor: 4.698

7.  Peroxisome Proliferator-Activated Receptor α Activation Suppresses Cytochrome P450 Induction Potential in Mice Treated with Gemfibrozil.

Authors:  Cunzhong Shi; Luo Min; Julin Yang; Manyun Dai; Danjun Song; Huiying Hua; Gangming Xu; Frank J Gonzalez; Aiming Liu
Journal:  Basic Clin Pharmacol Toxicol       Date:  2017-05-10       Impact factor: 4.080

8.  TGF-β-SMAD3 signaling mediates hepatic bile acid and phospholipid metabolism following lithocholic acid-induced liver injury.

Authors:  Tsutomu Matsubara; Naoki Tanaka; Misako Sato; Dong Wook Kang; Kristopher W Krausz; Kathleen C Flanders; Kazuo Ikeda; Hans Luecke; Lalage M Wakefield; Frank J Gonzalez
Journal:  J Lipid Res       Date:  2012-10-03       Impact factor: 5.922

9.  Modulation of fatty acid and bile acid metabolism by peroxisome proliferator-activated receptor α protects against alcoholic liver disease.

Authors:  Heng-Hong Li; John B Tyburski; Yi-Wen Wang; Steve Strawn; Bo-Hyun Moon; Bhaskar V S Kallakury; Frank J Gonzalez; Albert J Fornace
Journal:  Alcohol Clin Exp Res       Date:  2014-04-28       Impact factor: 3.455

10.  PPARα-independent action against metabolic syndrome development by fibrates is mediated by inhibition of STAT3 signalling.

Authors:  Huiying Hua; Julin Yang; Hante Lin; Yang Xi; Manyun Dai; Gangming Xu; Fuyan Wang; Lihong Liu; Tingqi Zhao; Jing Huang; Frank J Gonzalez; Aiming Liu
Journal:  J Pharm Pharmacol       Date:  2018-09-25       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.